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ABSTRACT: Three novel borosilicate bioactive glasses (BBGs) were prepared and used to investigate their bioactive and
antibacterial properties. The BBGs were prepared by melt-quenching using diﬀerent glass modiﬁers, i.e. Mg2+, Ca2+, and Sr2+, and
their amorphous nature was conﬁrmed by X-ray diﬀraction. Scanning electron microscopy with energy dispersive X-ray
spectroscopy allowed the visualization of apatite-like structures upon 7 days of immersion in simulated body ﬂuid. BBG-Ca
generated surface structures with a Ca/P ratio ≈1.67, while the surface of the BBG-Sr was populated with structures with a Sr/P
ratio ≈1.7. Moreover, bacterial tests showed that the BBG-Mg and BBG-Sr glasses (at concentrations of 9, 18, 36, and 72 mg/
mL) present antibacterial characteristics. In particular, BBG-Sr, at concentrations of 9 mg/mL, exhibited bacteriostatic activity
against Pseudomonas aeruginosa, and at concentrations ≥18 mg/mL it was able to eradicate this bacterium. These results evidence
an antibacterial activity dependent on the BBGs composition, concentration, and bacterial species. Cellular studies showed that
the developed BBGs do not present a statistically signiﬁcant cytotoxic eﬀect against Saos-2 cells after 3 days of culture, showing
better performance (in the cases of BBG-Ca and BBG-Sr) than commercial 45S5 Bioglass up to 7 days of culture. Overall, this
study demonstrates that BBGs can be eﬀectively designed to combine bioactivity and intrinsic antibacterial activity targeting bone
tissue engineering applications.
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1. INTRODUCTION
In recent years, tissue engineering has shown great promise for
the repair, replacement, and even regeneration of bone defects.
A large diversity of bioactive glasses (BGs) has been reported.
Usually they present enhanced capacity to interact with bone
due to their capability to form a hydroxyapatite layer (HA)
under simulated physiological conditions.1 The CaO:-
SiO2:Na2O:P2O5 system (45S5 Bioglass)
1 has been the gold
standard for BGs, but it has limitations, namely related with its
degradation rates. When transformed into glass ceramics, these
silica based BGs have slow degradation rates, after being
implanted, which makes it diﬃcult to match with the rate of
new tissue formation.2,3 The conversion of the BGs to a bone-
like HA is slow and often incomplete.2 Moreover, the huge
increase in joint and bone implant surgeries is usually
accompanied by an increase in the incidence of implant-related
bacterial infections. This can lead to the failure of the
implanta growing public health concern in developed
countries.4,5
A broad spectrum of bacterial species can be found at
implant sites, including Pseudomonas aeruginosa, Escherichia coli,
Staphylococcus aureus, and Staphylococcus epidermidis. These
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species have been associated with joint and bone infections.4,6
As an example, P. aeruginosa and S. aureus were reported by
Malizos et al.7 to be related with ankle and foot osteomyelitis
after surgical treatment. Consequently, it is becoming urgent to
develop double-edged materials capable of perfect bonds to
bone and that exhibit intrinsic antibacterial activity.
The borosilicate bioactive glasses (BBGs) have been gaining
interest due to the possibility to easily control their degradation
rates and due to their strong bioactivity.8,9 The compositional
ﬂexibility of these glasses is high and can be tailored to improve
BBGs osteogenic and angiogenic properties by the addition of
speciﬁc glass modiﬁers.10,11 On one hand, network formers
such as silicon and boron are well-known to stimulate bone
formation and precipitation of HA. Silicon is known to be
essential for diﬀerent processes, such as bone formation and
calciﬁcation.12,13 In addition, boron is related with the
improved adhesion of bone cells and bone resistance to
fracture.14 On the other hand, the therapeutic cations, such as
Mg2+,15,16 Ca2+,17 and Sr2+18,19 are involved in cells adhesion
and stability; apatite formation process and cell diﬀerentiation;
and bone formation and mineralization, respectively. In fact,
Sr2+ has been reported for the treatment of osteoporosis.20
Furthermore, several cations can provide antibacterial
properties to BGs. Speciﬁcally, silver,21 copper,22 and cerium23
can provide bacteriostatic and/or bactericidal properties to
BGs. Remarkably, other cations may also provide antibacterial
properties to BGs, as previously shown for Mg2+,24 Ca2+, and
Sr2+.25,26 In this context, the incorporation of diﬀerent cations
can impart a series of therapeutic features into BGs, and their
properties can be suited to meet the clinical needs.
Therefore, the main objective of this work is 2-fold: (1) to
develop three novel melt-quench BBGs, prepared with the glass
modiﬁers Ca2+, Sr2+, or Mg2+, that are able to present enhanced
bioactivity; (2) to investigate their intrinsic antibacterial
properties. We aimed to contribute to the development of
BBGs that couple bone regenerative properties with intrinsic
antibacterial activity relevant in the bone tissue engineering
context.
2. MATERIALS AND METHODS
2.1. Glasses’ fabrication. BBGs of general formula 0.05Na2O·
xMgO·yCaO·(0.35-x-y)SrO·0.20B2O3·0.40SiO2 (molar ratio, where x,
y = 0.35 or 0.00, and x ≠ y) were fabricated by melt-quenching. The
appropriate amounts of diboron trioxide (B2O3, Alfa Aesar, Germany),
sodium bicarbonate (NaHCO3, Sigma-Aldrich, Australia), silica gel 60
M (SiO2, Macherey-Nagel, Germany), and magnesium oxide (MgO,
Sigma-Aldrich, Portugal) or calcium carbonate (CaCO3, Sigma-
Aldrich, Portugal), or strontium carbonate (SrCO3, Sigma-Aldrich,
Portugal) were thoroughly mixed with addition of ethanol in a
porcelain mortar with the help of a pestle, dried overnight, and
transferred to a platinum crucible. Afterward, the batch was heated to
1450 °C in air for 1 h, and subsequently the melt was quickly poured
into cold water for a fast cooling step, forming a glass frit with no
crystalline phases. Afterward, pieces of the as-quenched glass were
quickly removed from water, dried to remove all the nonstructural
water, and ground in an Agate mortar (RETSCH, Germany). After
overnight vacuum drying, the glasses were sieved to a particle size
lower than 63 μm. Before the in vitro tests, the BBG-Mg, BBG-Ca, and
BBG-Sr were weighted and sterilized by ethylene oxide (the sterilizing
gas was composed by 88% CO2 and 12% ethylene oxide using the
following physical parameters: temperature of 45 °C ± 3 °C; pressure
of 180 + 3 kPa; humidity of 55 ± 10% HR; and exposure time of 10
h).
2.2. Glasses’ characterization. 2.2.1. Morphology and density.
Scanning electron microscopy (SEM) was used to observe the
morphology of the BBGs particles. Prior to the analysis, all BBGs
samples were sputter-coated with gold (sputter coater model SC502,
Fisons Instruments, England). All the micrographs were acquired on a
Leica Cambridge S360 microscope (Leica Cambridge, England) using
beam energy of 5.0 kV and working distance of ≈5.2 mm.
The BBGs density was determined using a multi pycnometer
(Quantachrome Instruments, USA). Measurements were performed
with helium at 110 °C using ≈5 g of each sample.
2.2.2. Crystallinity. X-ray powder diﬀraction (XRD) was used to
conﬁrm the amorphous state of BBGs. The BBGs diﬀractograms were
collected on a Bruker D8 Discover (Germany), operating with a Cu
Kα radiation θ/2θ mode between 10° and 60°, with a step increment
of 0.04° and an acquisition time of 1s per step.
2.2.3. Elemental composition. Inductively coupled plasma atomic
emission spectrometry (ICP-AES - Horiba, Japan) was used to
determine the elemental composition of the glasses (B, Si, Na, Ca, Sr,
and Mg) after total dissolution of 1 g of each BBG into hydroﬂuoric
acid. The sample absorption was measured at speciﬁc wavelengths (λ =
588.995 for Na, λ = 279.553 nm for Mg, λ= 393.366 nm for Ca, λ =
588.995 nm for Sr, λ = 249.773 nm for B, and λ = 251.611 nm for Si),
and their concentration was determined using calibration curves
obtained with standard solutions (VWR, Portugal) in the range from 5
× 103 to 10 ppm.
2.3. Bioactivity of the glasses. Simulated body ﬂuid (SBF) was
produced in accordance with the procedure described by Kokubo et
al.27 Triplicate samples of the prepared BBGs, with a particle size lower
than 63 μm, were immersed in SBF at a ratio of 10:15 [BBG (mg):
SBF (mL)] and incubated for 1, 3, and 7 days in an oven maintained at
37 °C. After each time point BBGs were recovered and dried at 37 °C.
The gold or carbon sputter coated samples were analyzed by SEM
(model S360, Leica Cambridge, England) equipped with energy
dispersive X-ray spectroscopy (SEM/EDS link-eXL-II) for morpho-
logical and chemical analysis.
2.4. Degradation of the glasses. Samples of the fabricated BBGs
were immersed in the bacterial growth medium Muller Hinton (MH)
(at least in triplicate) at concentrations of 9, 18, 36, and 72 mg/mL for
1, 3, and 7 days and maintained at 37 °C in a water-shaking bath at 60
rpm. At each time point, the solutions were ﬁltered and the pH was
assessed. The ICP-AES analyses were performed as described in
section 2.2.3 to determine the concentrations of Si, B, Mg, Ca, and Sr
released by the BBGs in MH.
2.5. Antibacterial properties. The standard disc diﬀusion (DD)
(2.5.1) and the broth dilution (BD) (2.5.2) assays28,29 were adapted to
test the ability of the BBGs to act against the Gram-negative bacteria P.
aeruginosa (American Type Culture Collection, ATCC 27853) and E.
coli (Coleccioń Española de Cultivos Tipo, CECT 434); and the
Gram-positive S. aureus (ATCC 25913) and S. epidermidis (strain
914230). These bacterial strains were chosen to represent a spectrum
of organisms associated with joint and bone infections.4 For these
experiments, diﬀerent concentrations [9, 18, 36, 72 mg/disc (DD) or/
mL (BD)] of each BBGs were used. Additionally, 45S5 Bioglass
(NOVABONE, USA) was used as commercial control; and culture
medium without BBGs was used as a negative control. The
antibacterial properties of BBGs as a function of the culture time
were investigated by BD assays for those glasses that exhibited
antibacterial activity on DD. All experiments were performed at least in
triplicate and repeated three times independently.
2.5.1. Disc diﬀusion assay. For the DD assay,28 agar discs (17g/L
(Lioﬁlchem, Portugal), Ø ≈ 9.5 mm) were charged with diﬀerent
concentrations of BBGs and used on the same day.
The direct colony suspension method was used to prepare a saline
suspension of each microbial species previously grown in Tryptone
Soya Agar (TSA, Lioﬁlchem, Portugal) at 37 °C for 18 h. The density
of the suspensions was adjusted to that of a McFarland 0.5 turbidity
standard, corresponding to approximately 1−2 × 108 colony forming
unit (CFU)/mL. The inoculum concentration was conﬁrmed by
enumeration of CFU after culture of serial dilutions onto TSA and
incubation at 37 °C, 18−24 h in air. The test was performed by
applying the bacterial inoculum with a sterile cotton swab onto the
surface of a MH agar (Lioﬁlchem, Portugal) plate containing 25 mL of
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medium. The glasses on agar discs were applied in the plates within 15
min of inoculation. The plates were incubated at 37 °C in air for 18 h
for all the bacteria. The diameter (in millimeters) of the inhibition
zone around each disc was measured using a ruler. The presence of an
inhibition halo was interpreted as bacterial susceptibility to the BBG.
2.5.2. Broth dilution assay. For the BD assay,29 the BBGs were
immersed in 0.5 mL of MH (Fluka, Portugal) medium and incubated
at 37 °C in air for 0, 2, or 6 days.
For each bacterium, the inoculum was prepared as described for the
DD test. It was diluted to approximately 1 × 106 CFU in 0.5 mL of
culture medium, added to the diﬀerent tubes containing known
amounts of BBGs dissolved during the speciﬁc time frames, and
incubated at 37 °C in air for 24 h. Overall, the bacteria were tested for
a ﬁxed period after 1, 3, and 7 days of BBGs dissolution in MH
medium. One sample was removed from each tube, serially diluted in
saline, and inoculated onto TSA. After 24 h incubation at 37 °C in air,
the number of colonies were counted. The results are presented as
log10 CFU/mL. Bacteriostatic and bactericidal activities were deﬁned
as a reduction of bacteria less and more than 3 log10 CFU/mL,
respectively, expressed as the proportion of the inoculum (number of
living CFUs introduced in culture) that is rendered incapable of
reproduction on subculture.31 Eradication was deﬁned as the
elimination of culturable bacteria upon subculture.
2.6. Cytotoxicity assay. The cytotoxicity assessment was
performed by adapting the ISO 10993 5:2009 to the targeted bone
tissue engineering application. The SaOs-2 cells derived from human
bone were cultured with BBGs at concentrations of 9, 18, 36, and 72
mg/mL during 7 days. The cells cultured in the absence of glass
particles were used as negative control, and in the presence of 45S5
Bioglass as positive control. Cells were expanded in Dulbecco’s
Modiﬁed Eagle Medium (Sigma, Portugal) supplemented with 10%
heat-inactivated fetal bovine serum (Alfagene, Portugal) and 1%
antibiotic/antimitotic solution (100U/mL penicillin and 100 μg/mL
streptomycin; Alfagene, Portugal). Cells were cultured at 37 °C in an
atmosphere of 5% CO2. Conﬂuent SaOs-2 cells between passages 15
and 19 were harvested and seeded onto the bottom of 24-well plates at
a density of 2.3 × 105 cells/well. The BBGs at the desired
concentrations and 45S5 Bioglass were added on top, in cell culture
inserts with porous membranes (0.4 μm ThinCerts Cell Culture
Inserts; Greiner, Germany). The fabricated BBGs presented great
biological performance without the common washing step before
contact with cells. Therefore, cytotoxicity assay of samples and control
(45S5 Bioglass) was performed without the common prewashing step.
The metabolic activity and cellular proliferation were monitored at
1, 3, and 7 days by MTS (3-(4,5-dimethylthiazol-2-yl)-5-(3-
carboxymethoxyphenyl)-2-(4-sulfophenyl)-2 H-tetrazolium − Prom-
ega, UK) and PicoGreen (Quant-iT PicoGreen dsDNA Assay Kit −
Invitrogen, USA), respectively, according to the supplier’s instructions.
2.7. Statistical analysis. Experiments were run at least in triplicate
for each sample. All the data were expressed as mean ± standard
deviation (SD). Statistical analysis was performed using Graphpad
Prim software, version 6.0. The normality of the data distribution was
monitored by Shapiro-Wilk test. Some of the data sets were not
considered to have a normal distribution, requiring a nonparametric
statistical evaluation. In this context, a Kruskal−Wallis test was applied
to all data sets, followed by a Dunn’s Multiple Comparison test. Values
of p < 0.001 were considered extremely signiﬁcant, those of 0.001<p <
0.01 were considered very signiﬁcant, and of those 0.01< p < 0.05 were
considered signiﬁcant.
3. RESULTS AND DISCUSSION
3.1. BBGs’ fabrication and characterization. The BBGs
network was designed to be a borosil icate (i .e. ,
0.2B2O3:0.4SiO2) containing diﬀerent network modiﬁers
following the general formula 0.05Na2O·xMgO·yCaO·(0.35-x-
y)SrO·0.20B2O3·0.40SiO2 (molar ratio, where x, y = 0.35 or
0.00, and x ≠ y). The BBGs were successfully obtained by melt-
quench and ground in a controlled manner. All the
compositions presented a density ranging from 2.5 to 3.0 g/
cm3. The increase of density was associated with the higher
molecular weight of the glass modiﬁer used to prepare the
BBG, i.e. Mg2+ < Ca2+ < Sr2+. Figure 1 presents the XRD data
obtained for the three compositions, which conﬁrm that the
melting procedure and the fast quenching in water were an
adequate strategy to obtain amorphous BBGs. In Figure 2
Figure 1. XRD patterns of the as-quenched glass frits, i.e. BBG-Mg, BBG-Ca, and BBG-Sr. Three replicates were performed for each sample, and
representative spectra are presented.
Figure 2. SEM micrographs of BBGs (BBG-Mg, BBG-Ca, and BBG-
Sr) before and after 1, 3, and 7 days of immersion in SBF. Higher SEM
magniﬁcations are shown as insets highlighting the apatite-like
structures. The 45S5 Bioglass was used as a control. The Ca/P or
Sr/P ratios on the surface of the BBGs were determined by EDS and
presented on the right corner from day 1 to 7. The asterisk (45S5
Bioglass) represents the theoretical value of the 45S5 Bioglass Ca/P
ratio. Scale bar = 0.25 μm.
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(column t0) are presented the SEM images of BBGs after the
grinding process. The BBGs exhibited an angular shape with
low sphericity. The ICP-AES analysis (Table 1) conﬁrmed the
elemental composition of the BBGs, showing values close to
the nominal theoretical composition.
3.2. BBGs in vitro bioactivity and degradation. The
formation of bone-like apatite structures was assessed after the
immersion of BBGs into the SBF buﬀer. Figure 2 presents the
SEM images and Ca/P ratios before and after 1, 3, and 7 days
of immersion into SBF. The in vitro bioactivity assay revealed
the presence of bone-like apatite structures onto the surface of
all the BBGs, even though they are at diﬀerent stages of
crystallization.
The BBG-Mg particles exhibited the formation of bone-like
apatite structures on their surface for days 1 and 3. However,
there was a decrease of those structures at day 7. In fact, Salimi
et al.32 showed that the Mg2+ has a marked inhibiting eﬀect on
HA growth due to its adsorption onto active growth sites. The
BBG-Ca and 45S5 Bioglass presented a constant increase in the
formation of bone-like apatite structures over time. Addition-
ally, the structures observed at days 1, 3, and 7 of immersion
presented the cauliﬂower-like morphology, typical of HA.
Moreover, at day 7 BBG-Ca reached Ca/P ≈ 1.67, which is
commonly associated with HA.33 Finally, at day 7 the BBG-Sr
glass also presented the formation of bone-like apatite
structures onto the particles’ surface with a cauliﬂower-like
morphology. These structures were formed during a longer
time period, and also they did not present the Ca/P ratio
expected for HA. However, the Sr/P ratio of BBG-Sr decreased
over time, reaching ≈1.7 at day 7. This suggests the formation
of strontium-substituted bone-like apatite (Sr-HA).34 Indeed,
Ravi et al.35 supported the use of Sr2+ in the place of Ca2+ in
HA structure forming synthetic Sr-HA. In fact, in the
mechanism for the formation of apatite-like structures,
proposed by Hench et al.,36 Sr2+ can replace Ca2+ and migrate
to the surface of the SiO2-rich layer precipitated on the surface
of BBGs, forming a SrO-P2O5-rich ﬁlm.
The BBG-Ca and BBG-Sr glasses have shown high capacity
to form bone-like apatite structures at their surface with cation/
P ratio ≈1.67 upon immersion in SBF, which might enable the
glasses to establish direct contact with living bone cells.37
In order to better understand the kinetics of BBGs
dissolution, a glass solubilization study was performed in MH
medium (Figure 3). For BBG-Mg and BBG-Sr there was a fast
initial glass dissolution up to day 3 and a subsequent slower
increase over time. In contrast, the BBG-Ca presented a faster
dissolution at day 1 followed by an increasing release over time.
However, the amounts of Mg2+ in BBG-Mg and of Sr2+ in BBG-
Sr derived-solutions were ≈3 times higher than that of Ca2+ in
the BBG-Ca derived solution (Figure 3c). This data shows that
the nature of the substituted cations inﬂuences diﬀerently their
release rate from the BBG network, which might induce
distinctive activities to cells. In fact, studies by Mestres et al.38
showed that the high Mg concentrations in the extracts of Mg-
containing cements contribute to their activity against E. coli
and P. aeruginosa by hyperosmotic stress. On the other hand,
the burst release of cations after 1 day led to an increase of pH
(≈1 unit of pH, Figure 3d), which might be related with the
observed BBGs antibacterial properties. Indeed, Zhang et al.,25
while studying BGs, correlated mainly the pH increase in the
solution with antibacterial activity. The lower release of Ca2+
into the BBG-Ca solution observed in the present work (Figure
3c) might explain the lower increase in the solution pH (Figure
3d), when compared with the dissolution solutions of BBG-Mg
and BBG-Sr (e.g., the average of all concentrations for BBG-Mg
at day 1 is 8.76, for BBG-Ca is 8.35, and for BBG-Sr is 8.90).
These results are also consistent with the observed release
proﬁles of Mg2+ and Sr2+ from the respective BBG
compositions over time (generating similar pH values ∼8.8−
8.9 in the degradation solutions). These variations in the release
kinetics of the divalent cations might inﬂuence diﬀerently the
ﬁnal BBGs properties, namely their bioactivity and antibacterial
capacities. In fact, Allan et al.39 reported that degradation of
Table 1. Elemental Composition of BBGs (BBG-Mg, BBG-Ca, and BBG-Sr) as Determined by ICPa
Sample Si (mol %) B (mol %) Divalent cationb (mol %) Na (mol %)
BBG-Mg 37.2 ± 0.2 (40) 17.0 ± 0.1 (20) 40.6 ± 0.1 (35) 4.9 ± 0.1 (5)
BBG-Ca 33.7 ± 0.3 (40) 21.0 ± 0.1 (20) 37.9 ± 0.3 (35) 7.3 ± 0.1 (5)
BBG-Sr 34.8 ± 0.3 (40) 21.0 ± 0.1 (20) 38.9 ± 0.3 (35) 5.1 ± 0.1 (5)
aThe data was obtained from three replicates and is presented as the mean of % molar composition in 1 g of sample (± standard deviation).
Theoretical values are presented in parentheses. bVaries with the diﬀerent divalent cations for each composition: Mg2+, Ca2+, and Sr2+, from top to
bottom.
Figure 3. Release of chemical species from the BBGs (BBG-Mg, BBG-
Ca, and BBG-Sr) into the MH medium (a−c) and the corresponding
pH of the solution (d) loaded with diﬀerent BBG concentrations (9−
72 mg/mL) after 1, 3, and 7 days of incubation at 37 °C under
agitation. The concentrations were assessed by ICP-AES. The data was
obtained from at least three independent samples and is expressed as
mean ± standard deviation (SD).
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45S5 Bioglass increases the pH, having an antibacterial eﬀect on
speciﬁc oral bacteria (e.g.: S. sanguis and Porphyromonas
gingivalis).
3.3. BBGs’ antibacterial properties. The susceptibility of
the Gram-negative (P. aeruginosa and E. coli) and Gram-positive
(S. aureus and S. epidermidis) bacterial species against variable
concentrations of BBGs was initially tested using the DD assay.
Table 2 shows the values of the zones of growth inhibition
around each BBG-containing disc. The results indicate that
45S5 Bioglass exhibited antibacterial activity against S.
epidermidis and P. aeruginosa, although a high concentration
was required to impair the growth of the latest species.
Regarding BBGs glasses, BBG-Mg showed antibacterial activity
against S. epidermidis and BBG-Sr activity against P. aeruginosa,
independently of the BBG’s concentration. In contrast, the
BBG-Ca did not present any detrimental eﬀect on the growth
of the studied bacterial species.
These promising results lead us to further characterize the
antibacterial properties of the developed BBG-Mg and BBG-Sr,
including the eﬀect of their dissolution over time by the BD
assay. The BD assay data indicates that BBG-Mg (Figure 4a)
prevented the growth of S. epidermidis, having a bacteriostatic
eﬀect, regardless of the BBG-Mg concentration used and the
time of dissolution (activity also observed for the control
sample, i.e. 45S5 Bioglass). Surprisingly, the BBG-Sr (Figure
4b), presented bactericidal activity against P. aeruginosa for all
the tested concentrations, although, at 9 mg/mL, for the ﬁrst
day, a bacteriostatic eﬀect was only observed with 2.6 log10
reduction in the initial inoculum. BBG-Sr was able to eradicate
P. aeruginosa at concentrations ≥18 mg/mL even at the ﬁrst
day of contact. This outperforms 45S5 Bioglass, which only
showed bacteriostatic or bactericidal activity at higher
concentrations and/or dissolution times against S. epidermidis
(Figure 4c) and P. aeruginosa (Figure 4d) [e.g., at the ﬁrst day
of dissolution, BBG-Sr at 18 mg/mL eradicated P. aeruginosa
(Figure 4c) while at the same concentration 45S5 Bioglass had
a bacteriostatic eﬀect (Figure 4d)]. Other authors also reported
bactericidal activity of 45S5 Bioglass: Brown et al.40 could
eradicate P. aeruginosa using a concentration of 50 mg/mL for a
period of 24 h incubation under 200 rpm shaking; Hu et al.41
also showed 99% bactericidal activity for concentrations higher
than 50 mg/mL against S. epidermidis, among other bacteria.
However, to our knowledge, this work describes for the ﬁrst
time BBGs that are able to eradicate bacteria with such a low
concentration of glass particles (i.e., 18 mg/mL).
Therefore, the BD assay allowed evaluating the concentration
dependence as well as the ability of BBG-Sr to eradicate P.
Table 2. BBGs (BBG-Mg, BBG-Ca, BBG-Sr) Antibacterial Activity against P. aeruginosa, E. coli, S. aureus, and S. epidermidis as
Assessed by the DD Assay at Variable BBG Concentrations (9−72 mg/disc) during 18 ha
P. aeruginosa E. coli S. aureus S. epidermidis
Sample Conc (mg/disc) Ø zone [min-max](mm) Ø zone [min-max] (mm) Ø zone [min-max] (mm) Ø zone [min-max] (mm)
BBG-Mg 9 0 0 0 11 [0−15]
18 0 0 0 12 [11−17]
36 0 0 0 11 [11−18]
72 0 0 0 12 [10−20]
BBG-Ca 9 0 0 0 0
18 0 0 0 0
36 0 0 0 0
72 0 0 0 0
BBG-Sr 9 17 [12−20] 0 0 0
18 17 [13-21] 0 0 0
36 16 [14−20] 0 0 0
72 18 [15−21] 0 0 0
45S5 Bioglass 9 0 0 0 11 [0−11]
18 0 0 0 14 [0−15]
36 0 0 0 16 [14−19]
72 11 [0−22] 0 0 20 [18−22]
aThe 45S5 Bioglass was used as a control. The data was obtained from at least three independent experiments and is expressed as the median [min−
max] values of the zones of growth inhibition around each glass agar disc measured in millimeters.
Figure 4. BBG-Mg antibacterial activity against S. epidermidis (a) and
of BBG-Sr against P. aeruginosa (c). Activity of 45S5 Bioglass against S.
epidermidis (b) and P. aeruginosa (d) used as control, while MH
without BBG was included as a bacterial positive growth control.
Bacterial cultures were assessed by the BD assay after 1, 3, and 7 days
of variable concentrations of BBGs (9−72 mg/mL) dissolution in MH
medium. Each bacterium was diluted to approximately 1 × 106 CFU in
0.5 mL of culture medium, added to the diﬀerent tubes containing
known amounts of BBGs dissolved during the speciﬁc time frames and
incubated at 37 °C in air for 24 h. The data was obtained from at least
three independent samples and is expressed as mean ± SD. Whenever
appropriate, the proportion of the initial inoculum that is rendered
incapable of reproduction on subculture is indicated on the top of the
bar as the mean log10 reduction. The initial inoculum concentration
(ii) and the detection limit (dl) are represented. For bacteria viable
counts below the detection limit, one-half of the detection limit is
presented (2 log CFU/mL).
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aeruginosa, as a complement to the DD assay. Thus, BBG-Sr
glasses presented relevant antibacterial properties, some of
them higher than the ones observed for commercial glasses
(e.g., Figure 4c and 4d). Several authors38,42 suggested the
inﬂuence of increased pH in the antibacterial activity. As an
example, Mestres et al.31 showed that magnesium phosphate
cements presented antibacterial activity against S. Sanguinis,
which was attributed to the alkaline pH. Also, ﬁndings from
Allan et al.39 revealed that supernates from 45S5 Bioglass
rapidly increase their pH to, approximately, 10. Therefore, the
authors suggested that the high pH alone could be responsible
for the observed antibacterial activity. In our case, the pH
variation between BBG-Sr 9 mg/mL and BBG-Sr 18 mg/mL at
day 1 was not signiﬁcant (Figure 3d, BBG-Sr), while variations
in the antibacterial activity were observed (from bacteriostatic
to bactericidal). Furthermore, the same pH value was recorded
for BBG-Mg 72 mg/mL at day 1 (Figure 3d, BBG-Mg) and it
only exhibited bactericidal activity against a diﬀerent bacterial
species (Figure 4). While a high pH has been associated with
the inhibition of bacterial growth, it is noteworthy that pH
might not be the only parameter inﬂuencing antibacterial
properties. Indeed, the release of speciﬁc cations has also been
shown to elicit an antibacterial eﬀect. For example, Ohtsu et
al.43 demonstrated that Sr2+ presents an antibacterial activity
against P. aeruginosa, through the contact of the bacterium with
a strontium borate pigment. In fact, both the release of Sr2+
from the BBG-Sr glass particles and its antibacterial activity
toward P. aeruginosa are dose dependent (Figure 3c and 4c).
This observation is consistent with the contribution of the
released Sr2+ to the antibacterial activity of BBG-Sr,25,35
suggesting that the BBG-Sr’s activity toward P. aeruginosa
may result from a synergist eﬀect of several independent factors
(e.g., Sr2+ release, pH increase, among others).
It is remarkable that in the case of BBG -Sr there is a
concentration dependence of the antibacterial activity.
Although, the interactions between BBGs and bacteria in in
vitro conditions are complex, these data suggest that the
incorporation of diﬀerent substituted cations in the BBGs
might be used to tune the antibacterial properties of the glasses.
3.4. In vitro cytotoxic evaluation. In order to be applied
as a biomaterial, it is of extreme relevance to study the potential
cytotoxic eﬀects of the developed BBGs. A screening of in vitro
BBGs cytotoxicity was performed with SaOs-2 cultures.
The MTS assay was used to assess the cell viability of Saos-2
cultured in the presence of BBGs for 7 days (Figure 5). Based
on previous works using the Bioglass 45S5 (the control in the
present work), the threshold for metabolic activity was set at
50%.44 The BBGs and the commercial control (45S5 Bioglass)
showed high cell viability for 3 days of culture. However, after 7
days of culture, a signiﬁcant reduction in cells viability was
observed for BBG-Mg and 45S5 Bioglass for all concentrations.
This might be related to the faster release rate of the alkali
cation, sodium, from the BBGs, when compared with calcium
and strontium. In fact, 45S5 Bioglass is composed of a high
sodium percentage (24.5%). On the other hand, Kansal et al.
showed that the increase of the Na+/Mg2+ ratio causes a
decrease in the chemical durability of glasses, which might
result in higher release of sodium.45 While for BBG-Ca and -Sr
glasses only at concentrations higher than 36 mg/mL was a
decay of viability noticed. In general, the three novel BBGs
exhibited similar or greater viability than 45S5 Bioglass (e.g., for
the concentration of 18 mg/mL, after 3 days of culture, Saos-2
viabilities were 90, 74, 60, and 66% for BBG-Mg, -Ca, -Sr, and
45S5 Bioglass, respectively).
Additionally, the cell proliferation proﬁle was assessed by
PicoGreen assay for 7 days of culture (Figure 6). The data
showed that cell proliferation decreases only after 7 days of
culture, reducing the Saos-2 population to half or less than half
the control cell population, corroborating with cell viability data
(Figure 5). The reduction of cell viability and proliferation over
Figure 5.Metabolic activity of SaOs-2 in the presence of BBG-Mg (a),
BBG-Ca (b), and BBG-Sr (c) assessed by MTS after 1, 3, and 7 days of
variable concentrations of BBGs (9−72 mg/mL) in the media. The
45S5 Bioglass (d) was used as control. Standard culture medium was
used as negative control. The data represents the relative metabolic
activity (expressed as percentage of the control). The data was
obtained from at least three independent samples and is expressed as
mean ± SD. Error bars represent standard deviations. The data was
analyzed by nonparametric statistics: Kruskal−Wallis test (p < 0.001),
followed by a Dunn’s Multiple Comparison test. *** Extremely
signiﬁcant (p < 0.001); ** Very signiﬁcant (0.001<p < 0.01); *
Signiﬁcant (0.01<p < 0.05). 1 with respect to day 1; 3 with respect to
day 3.
Figure 6. Cell proliferation of SaOs-2 in the presence of BBG-Mg (a),
BBG-Ca (b), and BBG-Sr (c) assessed by PicoGreen after 1, 3, and 7
days of variable concentrations of BBGs (9−72 mg/mL) in the media.
The 45S5 Bioglass (d) was used as control. Standard culture medium
was used as negative control. The data was obtained from at least three
independent samples and is expressed as mean ± SD. Error bars
represent standard deviations. The data was analyzed by non-
parametric statistics: Kruskal−Wallis test (p < 0.001), followed by a
Dunn’s Multiple Comparison test. *** Extremely signiﬁcant (p <
0.001); ** Very signiﬁcant (0.001<p < 0.01); * Signiﬁcant (0.01<p <
0.05). The statistical signiﬁcance of each condition was calculated in
relation to the negative control at the respective time point.
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time can be related with the release of cations (e.g., Mg2+, Ca2+,
Sr2+) to the culture medium and the resulting increase of pH,
which can be deleterious to cells by aﬀecting essential
biochemical reactions.46 Nevertheless, for a wide range of
concentrations, the BBGs showed higher number of cells with
respect to the 45S5 Bioglass. Notwithstanding the reduction of
cell number and viability over time, there are a wide variety of
BBG concentrations that do not present signiﬁcant cytotoxicity
to cells (taken as 50% of metabolic activity from previous
studies with 45S5 Bioglass44). Moreover, BBGs presented lower
cytotoxicity than the commercially available 45S5 Bioglass.47
Therefore, BBGs can be used to achieve medical-grade
materials that couple bone regeneration properties with
intrinsic antibacterial activity for the development of bio-
materials for bone tissue engineering applications.
The BGs provided a considerable set of new solutions for
bone implantation; however, the increase of surgical
interventions contributed to the escalation of the incidence of
bacterial bone infections. A large number of bone infections
cause implant failure and require revision surgery, which causes
prolonged hospitalization and occasionally leads to failure of
the implants.48 Moreover, nowadays, physicians are having
diﬃculties managing bacterial infections, due to the upsurge of
drug-resistance bacteria.49 Building on the promising results
from in vitro tests, BBGs can be used in the development of
medical-grade materials with intrinsic antibacterial properties
relevant for bone tissue engineering applications.
4. CONCLUSIONS
BBGs with diﬀerent substituted cations (Ca2+, Sr2+, or Mg2+)
were successfully fabricated by a melt-quenching technique. In
vitro studies revealed that the novel BBGs exhibit bioactive and
antibacterial properties relevant for bone tissue engineering
applications, with no cytotoxic eﬀects for most of the active
concentrations. Speciﬁcally, BBG-Ca (≈1.67 Ca/P ratio) and
BBG-Sr (≈1.67 Sr/P ratio) produced bone-like apatite
structures on the surface. BBG-Mg exhibited bacteriostatic
activity against S. epidermidis, although it did not reach the
activity observed for the control sample 45S5 Bioglass.
However, BBG-Sr presented bacteriostatic activity against P.
aeruginosa at a concentration of 9 mg/mL and was able to
eradicate this bacterium at higher concentrations (≥18 mg/
mL). Finally, this study demonstrated that BBGs can be used as
relevant biomaterials that present diﬀerent characteristics
appropriate for bone tissue engineering applications: providing
bone integration properties (BBG-Ca); antibacterial capacity
(BBG-Mg); or even coupled properties (BBG-Sr).
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